CD163 and schizophrenia: In support of our hypothesis, we saw increased gene expression and protein levels of the macrophage marker, CD163, in the region containing the dopamine cell bodies in schizophrenia, and these measures were most robustly increased in the schizophrenia cases with a high inflammatory biotype.